menu
    • menu

    Company profile for Cyclo Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cyclo Therapeutics, Inc. (previously CTD Holdings, Inc.) was organized as a Florida corporation on August 9, 1990, with operations beginning in July 1992. In conjunction with a restructuring in 2000, we changed our name from Cyclodextrin Technologies Development, Inc., or CTDI, to CTD Holdings, Inc.; CTDI was then incorporated as a Florida corporation and became a wholly owned subsidiary of CTD Holdings, Inc. We are a clinica...
    Cyclo Therapeutics, Inc. (previously CTD Holdings, Inc.) was organized as a Florida corporation on August 9, 1990, with operations beginning in July 1992. In conjunction with a restructuring in 2000, we changed our name from Cyclodextrin Technologies Development, Inc., or CTDI, to CTD Holdings, Inc.; CTDI was then incorporated as a Florida corporation and became a wholly owned subsidiary of CTD Holdings, Inc. We are a clinical stage biotechnology company focused on the use of cyclodextrins in drug development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cyclo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6714 NW 16th Street, Suite B Gainesville, FL 32616
    Telephone
    Telephone
    386-418-8060
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cyclotherapeutics.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/cyclotherapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cyclodexpert?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cyclo Reports Positive Data From Phase 3 TransportNPC in Patients
    Cyclo Reports Positive Data From Phase 3 TransportNPC in Patients

    07 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250207991863/en

    BUSINESSWIRE
    07 Feb 2025
    Share Share
    Cyclo Therapeutics to Present at 21st Annual WORLDSymposium 2025
    Cyclo Therapeutics to Present at 21st Annual WORLDSymposium 2025

    14 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250114456775/en

    BUSINESSWIRE
    14 Jan 2025
    Share Share
    Cyclo Therapeutics Reports Q3 2024 Results & Update
    Cyclo Therapeutics Reports Q3 2024 Results & Update

    14 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241114950998/en

    BUSINESSWIRE
    14 Nov 2024
    Share Share
    Cyclo Therapeutics Presents Phase 3 Safety Data for Niemann-Pick Disease C1
    Cyclo Therapeutics Presents Phase 3 Safety Data for Niemann-Pick Disease C1

    05 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240905016909/en

    BUSINESSWIRE
    05 Sep 2024
    Share Share
    Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
    Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement

    22 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240822425306/en

    BUSINESSWIRE
    22 Aug 2024
    Share Share
    Cyclo Therapeutics Reports Q2 2024 Financial Results And Update
    Cyclo Therapeutics Reports Q2 2024 Financial Results And Update

    15 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240815845065/en

    BUSINESSWIRE
    15 Aug 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Cyclo Therapeutics and get a quotation

    Cyclo Therapeutics is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Hydroxypropyl-Beta Cyclodextrin bulk with DMF offered by Cyclo Therapeutics

    Find a price of Chlorpromazine Hydrochloride bulk offered by Cyclo Therapeutics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search